Phase I Dose Escalation of Single-Agent Vinblastine in Dogs-Reference-Cited by-同舟云学术

Phase I Dose Escalation of Single-Agent Vinblastine in Dogs

Published:2008-11 Issue:6 Volume:22 Page:1397-1402
ISSN:0891-6640
Container-title:Journal of Veterinary Internal Medicine
language:en
Short-container-title:

Author:

Bailey D.B.,Rassnick K.M.,Kristal O.,Chretin J.D.,Balkman C.E.

Publisher

Wiley

Subject

General Veterinary

Reference41 articles.

1. 1. Rosenthal RC. Clinical applications of vinca alkaloids. J Am Vet Med Assoc 1981;179:1084, 1086.

2. 2. Golden DL , Langston VC. Uses of vincristine and vinblastine in dogs and cats. J Am Vet Med Assoc 1988;193:1114-1117.

3. 4. Thamm DH , Mauldin EA , Vail DM. Prednisone and vinblastine chemotherapy for canine mast cell tumor-41 cases (1992-1997). J Vet Intern Med 1999;13:491-497.

4. 5. Davies DR , Wyatt KM , Jardine JE , et al. Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors. J Am Anim Hosp Assoc 2004;40:124-130.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor Grade and Mitotic Count Are Prognostic for Dogs with Cutaneous Mast Cell Tumors Treated with Surgery and Adjuvant or Neoadjuvant Vinblastine Chemotherapy;Veterinary Sciences;2024-08-10

2. Tyrosine kinase inhibitors as an alternative treatment in canine mast cell tumor;Frontiers in Veterinary Science;2023-06-08

3. Skin and Subcutaneous Tumors;Veterinary Surgical Oncology;2022-02-11

4. Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors;Cells;2022-02-10

5. Are severe adverse events commonly observed in dogs during cancer chemotherapy? A retrospective study on 155 dogs;Veterinary and Comparative Oncology;2021-11-22